Stay updated on Anti-CD137 and Anti-CTLA-4 combo Clinical Trial.

Sign up to get notified when there's something new on the Anti-CD137 and Anti-CTLA-4 combo Clinical Trial. page.
Latest website image capture
Clouds background image

Latest updates to the Anti-CD137 and Anti-CTLA-4 combo Clinical Trial. page

  1. Check
    today
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-01T01:55:19.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    A banner announces that NIH is transitioning to use “Super Intelligence” in place of “Artificial Intelligence” and links to related updates and FAQs.
    Difference
    0.6%
    Check dated 2026-10-25T01:52:27.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T01:40:21.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision shown in the footer changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T01:59:53.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The Record History page received a visual refresh with updated layout and styling. The list of versions and the compare controls remain intact, preserving access to historical records and comparison functionality.
    Difference
    0.1%
    Check dated 2026-09-27T01:46:06.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The study record history now includes the latest revision, v3.7.0. This reflects an update to the entry since the prior revision, v3.6.6.
    Difference
    0.1%
    Check dated 2026-09-20T01:04:53.000Z thumbnail image

Stay in the know with updates to Anti-CD137 and Anti-CTLA-4 combo Clinical Trial.

Enter your email address, and we'll notify you when there's something new on the Anti-CD137 and Anti-CTLA-4 combo Clinical Trial. page.